USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	060594/0209			Pages:	11
		Recorded:	07/06/2022
Attorney Dkt #:	55525
Conveyance:	CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Total properties: 14

Patent #:	10800821	Issue Dt:	10/13/2020	Application #:	15566724	Filing Dt:	10/16/2017
Publication #:	US20180141986	Pub Dt:	05/24/2018
Title:	NOVEL RECOMBINANT BI-FUNCTIONAL FUSION PROTEIN AND PREPARATION AND APPLICATION THEREFOR

Patent #:	10973878	Issue Dt:	04/13/2021	Application #:	16170024	Filing Dt:	10/24/2018
Publication #:	US20190125834	Pub Dt:	05/02/2019
Title:	RECOMBINANT FUSION PROTEIN CONTAINING AN ANTI-PD-L1 ANTIBODY

Patent #:	11407841	Issue Dt:	08/09/2022	Application #:	16489360	Filing Dt:	08/28/2019
Publication #:	US20200095339	Pub Dt:	03/26/2020
Title:	RECOMBINANT BI-FUNCTIONAL FUSION PROTEIN AND USE THEREOF

Patent #:	11453724	Issue Dt:	09/27/2022	Application #:	16535075	Filing Dt:	08/08/2019
Publication #:	US20200048364	Pub Dt:	02/13/2020
Title:	RECOMBINANT BIFUNCTIONAL PROTEIN TARGETING CD47 AND HER2

Patent #:	11407832	Issue Dt:	08/09/2022	Application #:	16699732	Filing Dt:	12/02/2019
Publication #:	US20200172623	Pub Dt:	06/04/2020
Title:	RECOMBINANT PROTEIN TARGETING PD-L1 AND VEGF

Patent #:	NONE	Issue Dt:		Application #:	16905262	Filing Dt:	06/18/2020
Publication #:	US20210024598	Pub Dt:	01/28/2021
Title:	NOVEL RECOMBINANT BI-FUNCTIONAL FUSION PROTEIN TARGETING CD47 AND FCyR, PREPARATION,AND USE THEROF.

Patent #:	NONE	Issue Dt:		Application #:	17407404	Filing Dt:	08/20/2021
Publication #:	US20210380716	Pub Dt:	12/09/2021
Title:	RECOMBINANT BIFUNCTIONAL PROTEIN TARGETING CD47 AND HER2

Patent #:	NONE	Issue Dt:		Application #:	17412445	Filing Dt:	08/26/2021
Publication #:	US20210388043	Pub Dt:	12/16/2021
Title:	RECOMBINANT BI-FUNCTIONAL FUSION PROTEINS BINDING CD47 AND FC GAMMA RECEPTOR, PREPARATION AND USE THEREOF

Patent #:	11672859	Issue Dt:	06/13/2023	Application #:	17496051	Filing Dt:	10/07/2021
Publication #:	US20230083670	Pub Dt:	03/16/2023
Title:	RECOMBINANT FUSION PROTEINS TARGETING CD47 AND PD-L1, PREPARATION AND USE THEREOF

Patent #:	11891449	Issue Dt:	02/06/2024	Application #:	17543033	Filing Dt:	12/06/2021
Publication #:	US20230114491	Pub Dt:	04/13/2023
Title:	RECOMBINANT FUSION PROTEINS TARGETING CD47 AND CD24, PREPARATION AND USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17592976	Filing Dt:	02/04/2022
Publication #:	US20230110702	Pub Dt:	04/13/2023
Title:	RECOMBINANT FUSION PROTEINS TARGETING CD47 AND CD38, PREPARATION AND USE THEREOF

Patent #:	11613584	Issue Dt:	03/28/2023	Application #:	17685501	Filing Dt:	03/03/2022
Publication #:	US20230112123	Pub Dt:	04/13/2023
Title:	ANTIBODIES BINDING CD70, PREPARATION AND USE THEREOF

Patent #:	11926675	Issue Dt:	03/12/2024	Application #:	17685530	Filing Dt:	03/03/2022
Publication #:	US20230110607	Pub Dt:	04/13/2023
Title:	ANTIBODIES BINDING CD24, PREPARATION AND USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17737159	Filing Dt:	05/05/2022
Publication #:	US20220340664	Pub Dt:	10/27/2022
Title:	RECOMBINANT PROTEIN TARGETING PD-L1 AND VEGF

Assignor

Exec Dt:

06/14/2022

Assignee

BUILDING #15, LANE 1000, ZHANGHENG ROAD

PUDONG NEW DISTRICT

SHANGHAI, CHINA 201203

Correspondence name and address
	DEBORAH L. LU
	1540 BROADWAY
	DUANE MORRIS LLP
	NEW YORK, NY 10036

Search Results as of: 06/26/2024 10:58 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6